Postural Balance Effects Associated with 400, 4000 or 10,000 IU Vitamin D3 Daily for Three Years: A Secondary Analysis of a Randomized Clinical Trial

被引:7
|
作者
Burt, Lauren A. [1 ]
Gabel, Leigh [1 ]
Billington, Emma O. [1 ]
Hanley, David A. [1 ]
Boyd, Steven K. [1 ]
机构
[1] Univ Calgary, Cumming Sch Med, McCaig Inst Bone & Joint Hlth, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada
关键词
postural sway; sway index; clinical test of sensory interaction and balance; anterior-posterior; medio-lateral; aging; supplements; D SUPPLEMENTATION; DOUBLE-BLIND; POSTMENOPAUSAL WOMEN; MUSCLE FUNCTION; HEALTHY-YOUNG; OLDER-PEOPLE; RISK-FACTORS; FALLS; PREDICTORS; PERFORMANCE;
D O I
10.3390/nu12020527
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Vitamin D supplementation is proposed as a fall prevention strategy, as it may improve neuromuscular function. We examined whether three years of vitamin D supplementation (400, 4000 or 10,000 IU daily) affects postural sway in older adults. Three hundred and seventy-three non-osteoporotic, vitamin D-sufficient, community-dwelling healthy adults, aged 55-70 years, were randomized to 400 (n = 124), 4000 (n = 125) or 10,000 (n = 124) IU daily vitamin D-3 for three years. Sway index was assessed at baseline, 12-, 24- and 36-months using the Biosway machine. We tested participants under four conditions: eyes open or eyes closed with firm (EOFI, ECFI) or foam (EOFO, ECFO) surfaces. Secondary assessments examined sway in the anterior-posterior (AP) and medio-lateral (ML) directions. Linear mixed effects models compared sway between supplementation groups across time. Postural sway under EOFO and ECFO conditions significantly improved in all supplementation groups over time. Postural sway did not differ between supplementation groups at any time under any testing conditions in normal, AP or ML directions (p > 0.05 for all). Our findings suggest that high dose (4000 or 10,000 IU) vitamin D supplementation neither benefit nor impair balance compared with 400 IU daily in non-osteoporotic, vitamin D-sufficient, healthy older adults.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Effects of Supplementation with Vitamin D3 400, 4000 or 10000 IU Daily for Three Years on Vascular Calcification in The Calgary Vitamin D Study: Secondary Analysis of a Randomized Controlled Trial
    Billington, Emma
    Burt, Lauren
    Plett, Ryan
    Boyd, Steven
    Hanley, David
    Rose, Marianne S.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 27 - 27
  • [2] RANDOMIZED STUDY OF 4,000 IU, 6,000 IU, 8,000 IU OR 10,000 IU OF CHOLECALCIFEROL IN MEN WITH PROSTATE CANCER: TOXICITY AND 25(OH)D3 EFFECTS
    Trump, D. L.
    Al-Hussaini, M.
    Silliman, C.
    Nesline, M.
    Johnson, C. S.
    [J]. ANTICANCER RESEARCH, 2011, 31 (04) : 1496 - 1496
  • [3] Randomized supplementation of 4000 IU vitamin D3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial
    J. B. Ernst
    S. Prokop
    U. Fuchs
    J. Dreier
    J. Kuhn
    C. Knabbe
    H. K. Berthold
    S. Pilz
    I. Gouni-Berthold
    J. F. Gummert
    J. Börgermann
    A. Zittermann
    [J]. Nutrition Journal, 16
  • [4] Randomized supplementation of 4000 IU vitamin D3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial
    Ernst, J. B.
    Prokop, S.
    Fuchs, U.
    Dreier, J.
    Kuhn, J.
    Knabbe, C.
    Berthold, H. K.
    Pilz, S.
    Gouni-Berthold, I.
    Gummert, J. F.
    Boergermann, J.
    Zittermann, A.
    [J]. NUTRITION JOURNAL, 2017, 16
  • [5] 300,000 IU or 600,000 IU of oral vitamin D3 for treatment of nutritional rickets: A randomized controlled trial
    Mittal, Hema
    Rai, Sunita
    Shah, Dheeraj
    Madhu, S. V.
    Mehrotra, Gopesh
    Malhotra, Rajeev Kumar
    Gupta, Piyush
    [J]. INDIAN PEDIATRICS, 2014, 51 (04) : 265 - 272
  • [6] 300,000 IU or 600,000 IU of oral vitamin D3 for treatment of nutritional rickets: A randomized controlled trial
    Hema Mittal
    Sunita Rai
    Dheeraj Shah
    S. V. Madhu
    Gopesh Mehrotra
    Rajeev Kumar Malhotra
    Piyush Gupta
    [J]. Indian Pediatrics, 2014, 51 : 265 - 272
  • [7] A Phase 2 Trial Exploring the Effects of High-Dose (10,000 IU/Day) Vitamin D3 in Breast Cancer Patients With Bone Metastases
    Amir, Eitan
    Simmons, Christine E.
    Freedman, Orit C.
    Dranitsaris, George
    Cole, David E. C.
    Vieth, Reinhold
    Ooi, Wei S.
    Clemons, Mark
    [J]. CANCER, 2010, 116 (02) : 284 - 291
  • [8] Effect of vitamin D on all-causemortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily
    Zittermann, Armin
    Ernst, Jana B.
    Prokop, Sylvana
    Fuchs, Uwe
    Dreier, Jens
    Kuhn, Joachim
    Knabbe, Cornelius
    Birschmann, Ingvild
    Schulz, Uwe
    Berthold, Heiner K.
    Pilz, Stefan
    Gouni-Berthold, Ioanna
    Gummert, Jan F.
    Dittrich, Marcus
    Boergermann, Jochen
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (29) : 2279 - 2286
  • [9] The Calgary Vitamin D Study: Bone Microarchitecture Effects of Three-Year Supplementation With 400, 4000 or 10000 IU Daily
    Burt, Lauren A.
    Rose, Marianne S.
    Billington, Emma O.
    Raymond, Duncan A.
    Hanley, David A.
    Boyd, Steven K.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 21 - 21
  • [10] Daily Supplementation with 4000 IU Vitamin D3 for Three Years Does Not Modify Cardiovascular Risk Markers in Patients with Advanced Heart Failure: The Effect of Vitamin D on Mortality in Heart Failure Trial
    Zittermann, Armin
    Ernst, Jana B.
    Prokop, Sylvana
    Fuchs, Uwe
    Dreier, Jens
    Kuhn, Joachim
    Knabbe, Cornelius
    Borgermann, Jochen
    Berthold, Heiner K.
    Pilz, Stefan
    Gouni-Berthold, Ioanna
    Gummert, Jan F.
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2019, 74 (01) : 62 - 68